|
Reduced incidence of acute, refractory acute, and chronic rejection after liver transplantation with FK506-based immunosuppression. European FK506 Multicentre Liver Study Group. |
1994 |
Transplant. Proc. |
pmid:7527960
|
Neuhaus PJ |
Optimised first-line FK506-based protocols in liver transplantation: experience from the University Hospital Rudolf Virchow, Berlin. |
1994 |
Transplant. Proc. |
pmid:7527961
|
Sewing KF |
Pharmacokinetics, dosing principles, and blood level monitoring of FK506. |
1994 |
Transplant. Proc. |
pmid:7527962
|
Frei U and Wagner K |
Renal function in liver transplant patients receiving FK506 or cyclosporin A immunosuppressive therapy. |
1994 |
Transplant. Proc. |
pmid:7527963
|
Fukuzawa M and Okada A |
Analysis of mouse xenogeneic T-cell responses and the effect of FK 506 on these responses and on xeno-skin graft rejection. |
1994 |
Transplant. Proc. |
pmid:7513483
|
Morris R |
Modes of action of FK506, cyclosporin A, and rapamycin. |
1994 |
Transplant. Proc. |
pmid:7527964
|
Petuch BR et al. |
Microbial transformation of immunosuppressive compounds. III. Glucosylation of immunomycin (FR 900520) and FK 506 by Bacillus subtilis ATCC 55060. |
1994 |
J. Ind. Microbiol. |
pmid:7513528
|
Shaeffer MS et al. |
Interaction between FK506 and erythromycin. |
1994 |
Ann Pharmacother |
pmid:7513563
|
Lhöest GJ et al. |
15-Desmethyl FK-506 and 15,31-desmethyl FK-506 from human liver microsomes: isolation, identification (by fast atom bombardment mass spectrometry and NMR), and evaluation of in vitro immunosuppressive activity. |
1994 |
Clin. Chem. |
pmid:7513627
|
Ueda H et al. |
FR901228, a novel antitumor bicyclic depsipeptide produced by Chromobacterium violaceum No. 968. I. Taxonomy, fermentation, isolation, physico-chemical and biological properties, and antitumor activity. |
1994 |
J. Antibiot. |
pmid:7513682
|
Morozumi K and Takeda A |
[Kidney disorders induced by immunosuppressive agents]. |
1994 |
Nippon Naika Gakkai Zasshi |
pmid:7529294
|
Alamartine E et al. |
In-vitro effects of cyclosporin A, FK506, 6-mercaptopurine, and prednisolone on lymphokine-activated killer cells. |
1994 |
Nephrol. Dial. Transplant. |
pmid:7529381
|
Krentz AJ et al. |
Postoperative glucose metabolism in liver transplant recipients. A two-year prospective randomized study of cyclosporine versus FK506. |
1994 |
Transplantation |
pmid:7516590
|
Ludwig B et al. |
Characterization of Mip proteins of Legionella pneumophila. |
1994 |
FEMS Microbiol. Lett. |
pmid:7516906
|
Atcherson MM and Trifillis AL |
Cytotoxic effects of FK506 on human renal proximal tubule cells in culture. |
1994 |
In Vitro Cell. Dev. Biol. Anim. |
pmid:7529625
|
Murthy JN et al. |
Identification of a 14 kDa FK-506/rapamycin binding immunophilin from calf thymus. |
1994 |
Clin. Biochem. |
pmid:7532556
|
Maruyama K et al. |
FK 506 for vascular permeability factor production in minimal change nephrotic syndrome. |
1994 |
Nephron |
pmid:7517020
|
Donnelly JG and Soldin SJ |
Partial characterization of a 52 kDa CsA/FK506/rapamycin binding protein. |
1994 |
Clin. Biochem. |
pmid:7532557
|
High KP |
The antimicrobial activities of cyclosporine, FK506, and rapamycin. |
1994 |
Transplantation |
pmid:7517076
|
Fujisaki S et al. |
Effects of preformed antibodies induced by whole blood transfusion on small bowel transplantation. |
1994 |
Transplant. Proc. |
pmid:7518140
|
Spada M et al. |
Monitoring of intestinal myoelectrical activity after isolated small bowel transplantation in FK 506 immunosuppressed pigs. |
1994 |
Transplant. Proc. |
pmid:7518141
|
Spada M et al. |
Morphology of acute rejection and observation of lymphoproliferative hyperplastic reaction in FK 506 treated pigs after small bowel transplantation. |
1994 |
Transplant. Proc. |
pmid:7518142
|
Vischi S et al. |
The maltose absorption test does not predict allograft rejection of small bowel transplantation in FK 506 immunosuppressed pigs. |
1994 |
Transplant. Proc. |
pmid:7518143
|
Okamoto M et al. |
Detection of allograft rejection in rat small bowel transplantation by analysing the in situ distribution of S-phase lymphocytes. |
1994 |
Transplant. Proc. |
pmid:7518145
|
Yoshikawa N et al. |
Effect of FK-506 on xenografted human Graves' thyroid tissue is severe combined immunodeficient mice. |
1994 |
Clin. Endocrinol. (Oxf) |
pmid:7519528
|
Porayko MK et al. |
Nephrotoxic effects of primary immunosuppression with FK-506 and cyclosporine regimens after liver transplantation. |
1994 |
Mayo Clin. Proc. |
pmid:7508536
|
Kao PN et al. |
Cloning and expression of cyclosporin A- and FK506-sensitive nuclear factor of activated T-cells: NF45 and NF90. |
1994 |
J. Biol. Chem. |
pmid:7519613
|
Jindal RM et al. |
Diabetogenicity of FK506 versus cyclosporine in liver transplant recipients. |
1994 |
Transplantation |
pmid:7519799
|
Mor E et al. |
Reversal of severe FK506 side effects by conversion to cyclosporine-based immunosuppression. |
1994 |
Transplantation |
pmid:7519800
|
Connelly PR et al. |
Enthalpy of hydrogen bond formation in a protein-ligand binding reaction. |
1994 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:7510408
|
Kim YI et al. |
FK 506 prevents critical warm ischemia damage to the pig liver and improves hepatic microcirculation. |
1994 |
Transplant. Proc. |
pmid:7520636
|
Shiraga T et al. |
Metabolism of FK506, a potent immunosuppressive agent, by cytochrome P450 3A enzymes in rat, dog and human liver microsomes. |
1994 |
Biochem. Pharmacol. |
pmid:7510480
|
Hirai T et al. |
A short course of FK506 can induce limited donor-specific graft acceptance. |
1994 |
Ann. Thorac. Surg. |
pmid:7520685
|
Kuwano K and Arai S |
The inhibitory effect of FK506 on cytotoxic T-lymphocyte killing. |
1994 |
Immunol. Lett. |
pmid:7536706
|
Hossain M et al. |
Effects of various drugs (staurosporine, herbimycin A, ketotifen, theophylline, FK506 and cyclosporin A) on eosinophil viability. |
1994 |
Arerugi |
pmid:7520689
|
Bell A et al. |
Roles of peptidyl-prolyl cis-trans isomerase and calcineurin in the mechanisms of antimalarial action of cyclosporin A, FK506, and rapamycin. |
1994 |
Biochem. Pharmacol. |
pmid:7520696
|
Okamoto S et al. |
The interleukin-8 AP-1 and kappa B-like sites are genetic end targets of FK506-sensitive pathway accompanied by calcium mobilization. |
1994 |
J. Biol. Chem. |
pmid:7510691
|
Nichols RA et al. |
Calcineurin-mediated protein dephosphorylation in brain nerve terminals regulates the release of glutamate. |
1994 |
J. Biol. Chem. |
pmid:7522234
|
Nakagawa H et al. |
Tacrolimus ointment for atopic dermatitis. |
1994 |
Lancet |
pmid:7522297
|
Sharkey J and Butcher SP |
Immunophilins mediate the neuroprotective effects of FK506 in focal cerebral ischaemia. |
1994 |
Nature |
pmid:7522303
|
Bram RJ and Crabtree GR |
Calcium signalling in T cells stimulated by a cyclophilin B-binding protein. |
1994 |
Nature |
pmid:7522304
|
Tanaka A et al. |
Living related liver transplantation across ABO blood groups. |
1994 |
Transplantation |
pmid:7522363
|
Apanay DC et al. |
Cyclosporine increases the oxidizability of low-density lipoproteins in renal transplant recipients. |
1994 |
Transplantation |
pmid:7524202
|
Steinmüller TM et al. |
The effect of FK506 versus cyclosporine on glucose and lipid metabolism--a randomized trial. |
1994 |
Transplantation |
pmid:7524203
|
Singh N et al. |
Infectious complications in liver transplant recipients on tacrolimus. Prospective analysis of 88 consecutive liver transplants. |
1994 |
Transplantation |
pmid:7524204
|
Takahara S et al. |
Clinical evaluation of trough levels and area under the curve in cyclosporine- and FK 506-treated kidney transplant recipients. |
1994 |
Transplant. Proc. |
pmid:7524219
|
Ishioka M et al. |
FK506 treatment of noninfectious uveitis. |
1994 |
Am. J. Ophthalmol. |
pmid:7526689
|
Carroll PB et al. |
Effect of tacrolimus (FK506) in dystrophic epidermolysis bullosa: rationale and preliminary results. |
1994 |
Arch Dermatol |
pmid:7526802
|
Lauerma AI et al. |
Topical FK506: suppression of allergic and irritant contact dermatitis in the guinea pig. |
1994 |
Arch. Dermatol. Res. |
pmid:7526805
|
Bush KT et al. |
Induction of the FK506-binding protein, FKBP13, under conditions which misfold proteins in the endoplasmic reticulum. |
1994 |
Biochem. J. |
pmid:7526846
|
Kahan BD |
New immunosuppressive drugs--pharmacologic approaches to alter immunoregulation. |
1994 |
Ther Immunol |
pmid:7584478
|
Hamajima E et al. |
Effects of FK506, an immunosuppressive agent, on genesis of water-immersion stress-induced gastric lesions in rats. |
1994 |
Dig. Dis. Sci. |
pmid:7512015
|
Matsumoto T et al. |
Preventive effect of immunosuppressive agents against indomethacin-induced small intestinal ulcers in rats. |
1994 |
Dig. Dis. Sci. |
pmid:7512017
|
Todo S et al. |
Small intestinal transplantation in humans with or without the colon. |
1994 |
Transplantation |
pmid:7512291
|
Otto G et al. |
Corticosteroids and concomitant medication in the European multicentre study of FK 506 and cyclosporin in primary liver transplantation. |
1994 |
Transpl. Int. |
pmid:11271338
|
Wong P et al. |
FK 506 rescue therapy for intractable liver allograft rejection. |
1994 |
Transpl. Int. |
pmid:11271339
|
Mor E et al. |
Comparison of short and long-term renal function in liver transplant patients receiving cyclosporin or FK 506. |
1994 |
Transpl. Int. |
pmid:11271340
|
Uemoto S et al. |
Long-term use of FK 506 in living related liver transplantation. |
1994 |
Transpl. Int. |
pmid:11271341
|
Lhoëst G et al. |
Isolation and identification of a novel isomerized epoxide metabolite of FK-506 from erythromycin-induced rabbit liver microsomes. |
1993 Sep-Oct |
Drug Metab. Dispos. |
pmid:7694828
|
Iwasaki K et al. |
Isolation, identification, and biological activities of oxidative metabolites of FK506, a potent immunosuppressive macrolide lactone. |
1993 Nov-Dec |
Drug Metab. Dispos. |
pmid:7507815
|
Fukuse T et al. |
Combined therapy with FK-506 and cyclosporine for canine lung allotransplantation: immunosuppressive effects and blood trough levels. |
1993 Nov-Dec |
J. Heart Lung Transplant. |
pmid:7508750
|
Morris RE |
New small molecule immunosuppressants for transplantation: review of essential concepts. |
1993 Nov-Dec |
J. Heart Lung Transplant. |
pmid:7508752
|
Schreier MH |
Immunophilins and immunosuppression. |
1993 Mar-Apr |
Clin. Exp. Rheumatol. |
pmid:7686830
|
Piekoszewski W et al. |
Disposition of tacrolimus (FK 506) in rabbits. Role of red blood cell binding in hepatic clearance. |
1993 Jul-Aug |
Drug Metab. Dispos. |
pmid:7690698
|
Kobayashi J et al. |
A new rat infection-heart transplant model: effect of infection on graft survival studies. |
1993 Jul-Aug |
J. Heart Lung Transplant. |
pmid:7690253
|
|
Japanese study of FK 506 on kidney transplantation: results of late phase II study. |
1993 |
Transplant. Proc. |
pmid:7679831
|
Kobayashi M et al. |
Production of monoclonal antibody against recombinant human FKBP-12 and subcellular localization of FKBP-12 in human mononuclear and polymorphonuclear cells. |
1993 |
Transplant. Proc. |
pmid:7679832
|
Kuroki H et al. |
Effect of FK 506 and donor-specific blood transfusion on the rat composite tissue limb allograft and the mechanism of long-term graft survival. |
1993 |
Transplant. Proc. |
pmid:7679833
|
Egan DA et al. |
Equilibrium denaturation of recombinant human FK binding protein in urea. |
1993 |
Biochemistry |
pmid:7680574
|
Lionetti P et al. |
Activation of mucosal V beta 3+ T cells and tissue damage in human small intestine by the bacterial superantigen, Staphylococcus aureus enterotoxin B. |
1993 |
Eur. J. Immunol. |
pmid:7680613
|
Nelson PA et al. |
Immunosuppressive activity of [MeBm2t]1-, D-diaminobutyryl-8-, and D-diaminopropyl-8-cyclosporin analogues correlates with inhibition of calcineurin phosphatase activity. |
1993 |
J. Immunol. |
pmid:7680683
|
Piekoszewski W and Jusko WJ |
Plasma protein binding of tacrolimus in humans. |
1993 |
J Pharm Sci |
pmid:7680714
|
Ishizuka J et al. |
Effects of FK506 and cyclosporine on dynamic insulin secretion from isolated dog pancreatic islets. |
1993 |
Transplantation |
pmid:7506454
|
Dhar DK et al. |
Effective prevention of ischemic injury of the dearterialized canine liver by FK506 pretreatment. |
1993 |
Transplantation |
pmid:7506456
|
Fabrega AJ et al. |
Enhancement of allograft survival by single intraoperative donor-specific blood transfusion combined with FK506. |
1993 |
Transplantation |
pmid:7506458
|
Liu J |
FK506 and cyclosporin, molecular probes for studying intracellular signal transduction. |
1993 |
Immunol. Today |
pmid:7691065
|
Mori T et al. |
FK-506: a new immunosuppressive agent, failed to reduce cerebral vasospasm after experimental subarachnoid hemorrhage. |
1993 |
J. Vet. Med. Sci. |
pmid:7691190
|
Distant DA and Gonwa TA |
The kidney in liver transplantation. |
1993 |
J. Am. Soc. Nephrol. |
pmid:7691205
|
Sperr WR et al. |
[Effector cells in allergy: biological principles and new pharmacologic concepts]. |
1993 |
Wien. Klin. Wochenschr. |
pmid:7508662
|
Dawson TM et al. |
Immunosuppressant FK506 enhances phosphorylation of nitric oxide synthase and protects against glutamate neurotoxicity. |
1993 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:7694293
|
Spencer DM et al. |
Controlling signal transduction with synthetic ligands. |
1993 |
Science |
pmid:7694365
|
Travis J |
Making molecular matches in the cell. |
1993 |
Science |
pmid:7694368
|
Jusko WJ and Kobayashi M |
Therapeutic monitoring of tacrolimus (FK 506) |
1993 |
Ther Drug Monit |
pmid:7694395
|
Wagner JA et al. |
Failure of FK 506 to suppress the T cell-mediated immunity of mice to Listeria monocytogenes. |
1993 |
Clin. Exp. Immunol. |
pmid:7685672
|
Pilot-Matias TJ et al. |
High-level synthesis of the 12-kDa human FK506-binding protein in Escherichia coli using translational coupling. |
1993 |
Gene |
pmid:7685727
|
Akamine S et al. |
[Effect of FK-506 on bronchial healing of canine lung allografts]. |
1993 |
Nihon Kyobu Geka Gakkai Zasshi |
pmid:7685803
|
Partaledis JA and Berlin V |
The FKB2 gene of Saccharomyces cerevisiae, encoding the immunosuppressant-binding protein FKBP-13, is regulated in response to accumulation of unfolded proteins in the endoplasmic reticulum. |
1993 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:7685904
|
Emond JC et al. |
Improved results of living-related liver transplantation with routine application in a pediatric program. |
1993 |
Transplantation |
pmid:7682738
|
Kai N et al. |
Prevention of insulitis and diabetes in nonobese diabetic mice by administration of FK506. |
1993 |
Transplantation |
pmid:7682740
|
Hirakawa K et al. |
[The effect of perioperative portal venous inoculation with donor lymphocytes in combination with immunosuppressive agents on rat cardiac allograft survivals]. |
1993 |
Nihon Geka Gakkai Zasshi |
pmid:7688065
|
Entani C et al. |
Effect of a novel immunosuppressant, FK506, on spontaneous lupus nephritis in MRL/MpJ-lpr/lpr mice. |
1993 |
Nephron |
pmid:7688103
|
Ueki M et al. |
Diabetogenic effects of FK506 on renal subcapsular islet isografts in rat. |
1993 |
Diabetes Res. Clin. Pract. |
pmid:7688276
|
Abu-Elmagd K et al. |
Resolution of severe pyoderma gangrenosum in a patient with streaking leukocyte factor disease after treatment with tacrolimus (FK 506). |
1993 |
Ann. Intern. Med. |
pmid:7689802
|
Christensen BG |
FK-506: its role in immunosuppression. |
1993 |
Ann. N. Y. Acad. Sci. |
pmid:7689803
|
Kino T and Goto T |
Discovery of FK-506 and update. |
1993 |
Ann. N. Y. Acad. Sci. |
pmid:7689804
|
Parsons WH et al. |
FK-506--a novel immunosuppressant. |
1993 |
Ann. N. Y. Acad. Sci. |
pmid:7689805
|
Kawai M et al. |
Structure-activity profiles of macrolactam immunosuppressant FK-506 analogues. |
1993 |
FEBS Lett. |
pmid:7678400
|
Van Duyne GD et al. |
Atomic structures of the human immunophilin FKBP-12 complexes with FK506 and rapamycin. |
1993 |
J. Mol. Biol. |
pmid:7678431
|
Meadows RP et al. |
Three-dimensional structure of the FK506 binding protein/ascomycin complex in solution by heteronuclear three- and four-dimensional NMR. |
1993 |
Biochemistry |
pmid:7678499
|
Jiang H et al. |
Anti-tumor-promoting action of FK506, a potent immunosuppressive agent. |
1993 |
Carcinogenesis |
pmid:7678785
|